Results 151 to 160 of about 77,015 (216)

Investigating the Incremental Cost and Utilization Burden of Obstructive Sleep Apnea in Overweight to Severely Obese Patients

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To quantify the incremental economic and utilization burden of comorbid obstructive sleep apnea (OSA) within an overweight to severely obese adult population. Material and Methods This retrospective cohort study utilized 2016–2025 IQVIA PharMetrics Plus Closed Health Plan commercial claims data to identify overweight to severely obese ...
Hyung Seok John Kim, Tien Hoang Tran, Christopher N. Schmickl, Julia F. Slejko   +3 more
wiley   +1 more source

Functional Group Distribution Shapes Chemical Properties of Degraded Terrestrial and Marine Dissolved Organic Matter. [PDF]

Environ Sci Technol
Matos RR, Craig A, Koch BP, Hawkes J, Moodie LWK, Ivanova A, Gleixner G, Guth P, Knorr KH, Tebben J, Reemtsma T, Zherebker A, Lechtenfeld OJ.   +12 more
europepmc   +1 more source

Impact of circulation on export production, dissolved organic matter and dissolved oxygen in the ocean: Results from OCMIP-2 [PDF]

, 2007
Aumont, O., Caldeira, K., Doney, S. C., Dutay, J. C., Follows, M., Gruber, N., Jin, X., Joos, F., Lindsay, K., Louanchi, F., Maier-Reimer, E., Matear, R. J., Matsumoto, K., Monfray, P., Mouchet, A., Najjar, R. G., Orr, J. C., Plattner, G. K., Sarmiento, J., Schlitzer, Reiner, Weirig, M. F., Yamanaka, Y., Yool, A.   +22 more
core  

Acute GIP and GLP‐1 Administration Exerts Differential Metabolic Effects in Totally Pancreatectomised Individuals

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims While being recognised for stimulating pancreatic insulin secretion, GIP and GLP‐1 exert various extrapancreatic effects relevant in the context of incretin‐based therapies. Here, we evaluated the extrapancreatic effects of GIP and GLP‐1, separately and combined, on postprandial physiology in totally pancreatectomised individuals ...
Liva S. L. Krogh, Maja B. Hansen, Natasha C. Bergmann, Carsten P. Hansen, Bolette Hartmann, Jens J. Holst, Filip K. Knop, Asger B. Lund, Lærke S. Gasbjerg   +8 more
wiley   +1 more source

Comparability of Liquid Chromatography Tandem Mass Spectrometry Analysis of Dissolved Organic Matter across Laboratories. [PDF]

Environ Sci Technol
Kalinski JC, Ruiz Brandão da Costa B, Schramm T, Buckett LR, Carlson LT, Coffey NR, Damiani T, Dechent E, Abiead YE, Heuckeroth S, Jennings EK, Kaesler J, Stock NL, Orme AM, Torres RR, Trojahn S, Whelton HL, Yan Y, Aron AT, Boiteau RM, Bull ID, Dorrestein PC, Dang DH, Evershed RP, Gledhill M, Gleixner G, Haas AF, Hansen M, Harder T, Hopmans EC, Ingalls AE, Karst U, Kew W, Kido Soule M, Koch BP, Kujawinski EB, Lechtenfeld OJ, Longnecker K, Pluskal T, Pohnert G, Redman ZC, Rivas-Ubach A, Schmitt-Kopplin P, Singer G, Tebben J, Tomco PL, Ward ND, Aluwihare LI, Simon C, Hawkes J, Petras D.   +50 more
europepmc   +1 more source

Comparative Effects of Emerging Lp(a)‐Lowering Agents and PCSK9‐Directed Therapies on Lipoprotein(a): A Network Meta‐Analysis of Randomised Clinical Trials

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Elevated lipoprotein(a) [Lp(a)] is a genetic ASCVD risk factor that often persists despite intensive LDL‐C lowering. We compared the efficacy and safety of emerging Lp(a)‐targeted therapies (siRNAs, antisense oligonucleotides and an oral assembly inhibitor) with PCSK9‐directed therapies.
Jihad Abu Zayed, Nada A. Al‐Awamleh, Mahmoud Hamad, Mohammad Ibrahim Mahmoud Hdaib, Hazem Ayesh   +4 more
wiley   +1 more source

Soil carbon residence time regulates the age of dissolved organic matter in global rivers. [PDF]

Natl Sci Rev
Liu Z, Zhou Y, Rocher-Ros G, Dean JF, Middelburg JJ, Regnier P, Karlsson J, Zhang L, Lin W, Wang C, Zhou L, Wang J, Zhang Y, Woolway RI, Drake TW, Spencer RGM, Leavitt PR.   +16 more
europepmc   +1 more source

Fluorescence Quenching as a Diagnostic Tool for Prediction Reliability Assessment and Anomaly Detection in EEM-Based Water Quality Monitoring. [PDF]

Environ Sci Technol
Hu Y, Jacquin C, Morgenroth E.
europepmc   +1 more source

Multi‐Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Empagliflozin is renoprotective in Type 2 diabetes mellitus (T2DM). Our primary aim was to assess empagliflozin's effect on glomerular filtration rate and renal vascular resistance using multiparametric MRI (MpMRI). Our secondary aim was to assess the impact of empagliflozin on additional MpMRI‐derived metrics including markers of tissue ...
Ruth P. Lim, Salma Qassin, Lucy McKenna, Emma Hornsey, Dominic Italiano, Leonid Churilov, Richard J. MacIsaac, Jas‐mine Seah, Elif I. Ekinci, The Austin EMPA‐MRI Study Group   +9 more
wiley   +1 more source